BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15368335)

  • 1. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it?
    Bercovitch M; Adunsky A
    Cancer; 2004 Sep; 101(6):1473-7. PubMed ID: 15368335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the Time of Hospice and Palliative Care Enrollment before Death on Morphine, Length of Stay, and Healthcare Expense in Patients with Cancer in Taiwan.
    Liao YS; Tsai WC; Chiu LT; Kung PT
    Healthcare (Basel); 2023 Oct; 11(21):. PubMed ID: 37958010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of opioid dose between home palliative care and hospital palliative care.
    Iwata H; Hamada S; Harada H; Kusaka K
    BMC Prim Care; 2024 Jan; 25(1):33. PubMed ID: 38263008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-of-life care for patients with cancer: Clinical, geographical, and sociocultural differences.
    Ostan R; Varani S; Pannuti F; Pannuti R; Biasco G; Bruera E
    Palliat Support Care; 2024 Feb; 22(1):155-162. PubMed ID: 36779268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telehospice for Cancer Patients Discharged from a Tertiary Care Hospital in Western Kenya.
    Cornetta K; Nyariki S; Manji I; Kiplimo I; Korir M; Muinga E; Busakhala N; Elias H
    J Pain Symptom Manage; 2023 May; 65(5):378-387. PubMed ID: 36773732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing intractable pain with neuraxial infusion at home.
    Jones SE; Bird K; Maynard L
    Int J Palliat Nurs; 2023 Aug; 29(8):394-401. PubMed ID: 37620142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose controlled-release oxycodone in hospice care.
    Bercovitch M; Adunsky A
    J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between opioid dose escalation and time to death in a comfort measures only population.
    Abraham DL; Hernandez I; Ayers GT; Pruskowski JA
    Am J Health Syst Pharm; 2021 Jan; 78(3):203-209. PubMed ID: 33064125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal-release oral morphine starting dose in cancer patients with pain.
    Ripamonti CI; Campa T; Fagnoni E; Brunelli C; Luzzani M; Maltoni M; De Conno F;
    Clin J Pain; 2009 Jun; 25(5):386-90. PubMed ID: 19454871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between different opioid doses and the survival of advanced cancer patients receiving palliative care.
    Sathornviriyapong A; Nagaviroj K; Anothaisintawee T
    BMC Palliat Care; 2016 Nov; 15(1):95. PubMed ID: 27871265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Additional doses of oral morphine on demand].
    Amano N
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():374-7. PubMed ID: 8849278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid use and survival at the end of life: a survey of a hospice population.
    Portenoy RK; Sibirceva U; Smout R; Horn S; Connor S; Blum RH; Spence C; Fine PG
    J Pain Symptom Manage; 2006 Dec; 32(6):532-40. PubMed ID: 17157755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids, survival, and advanced cancer in the hospice setting.
    Azoulay D; Jacobs JM; Cialic R; Mor EE; Stessman J
    J Am Med Dir Assoc; 2011 Feb; 12(2):129-34. PubMed ID: 21266289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adverse effects of morphine: a prospective survey of common symptoms during repeated dosing for chronic cancer pain.
    Glare P; Walsh D; Sheehan D
    Am J Hosp Palliat Care; 2006; 23(3):229-35. PubMed ID: 17060284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid needs of patients with advanced cancer and the morphine dose-limiting law in Egypt.
    Alsirafy SA; El-Mesidi SM; El-Sherief WA; Galal KM; Abou-Elela EN; Aklan NA
    J Palliat Med; 2011 Jan; 14(1):51-4. PubMed ID: 21244253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational use and effectiveness of morphine in the palliative care of cancer patients at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania.
    Kamuhabwa A; Ezekiel D
    Tanzan J Health Res; 2009 Oct; 11(4):170-4. PubMed ID: 20734695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rehydration in palliative and terminal care: if not--why not?
    Dunphy K; Finlay I; Rathbone G; Gilbert J; Hicks F
    Palliat Med; 1995 Jul; 9(3):221-8. PubMed ID: 7582178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
    Juba KM; Wahler RG; Daron SM
    J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid Use and Outcomes in Hospitalized Older Patients With Heart Failure Receiving and Not Receiving Hospice Referrals.
    Sheriff HM; Arundel C; Gill GS; Tummala LS; Zeng Q; Theisen-Toupal JC; Morgan CJ; Faselis C; Allman RM; Singh S; Ahmed A
    Am J Ther; 2020; 27(4):e356-e365. PubMed ID: 31145140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.